GLYCOLYSIS PATHWAY (PW:0000640) Description
Glucose is a major source of energy in the cell. In the first round of
breakdown - a pathway known as glycolysis, one of the best
characterized biochemical pathways - one molecule of glucose is
converted to two molecules of pyruvate with a net yield of 2 ATP and
the reduction of 2 NAD+ to 2 NADH. The 10 enzymatic reactions of
glycolysis can be divided into two stages: an energy consumption stage
I (reactions 1 to 5) and an energy recovery/generation stage II
(reactions 6 to 10). Once transported into the cell, glucose is
phosphorylated to G6P by hexokinases (Hk). Phosphoglucose isomerase
(Gpi) converts G6P to F6P which is then phosphorylated to FBP by
phosphofrucokinases (Pfk) in the second energy-consuming and the most
important rate-determining step of the pathway. In reaction 4,
aldolases (Aldo) cleave FBP to two trioses: GAP and DHAP. Only GAP is
further used in the pathway; the isomerization of the two ketose-aldose
isomers is carried out by triose phosphate isomerase (Tpi1) in the 5th
and final reaction of stage I. Reactions 6 and 7 are coupled:
the glyceraldehyde-3-phosphate dehydrogenase (Gapdh)-catalyzed reaction
yields the 'high-energy' 1,3-BPG and in the process NAD
+ is reduced to
NADH; the phosphoglycerate kinase (Pgk1)-mediated reaction yields ATP and
3PG. The interconversion of 3PG to 2PG is carried out by
phosphoglycerate mutase (Pgam). 2PG is dehydrated by enolases (Eno) to
form the second 'high-energy' compound PEP. In reaction 10, the
final step of stage II, pyruvate kinases yield ATP and pyruvate. Under
aerobic conditions, pyruvate can be completely oxidized in the citric acid
cycle pathway, the second round of breakdown. Under anaerobic conditions pyruvate is converted to
lactate (muscle). Pyruvate can also be used to regenerate glucose
(gluconeogenesis pathway). As necessary, glucose can be stored as
glycogen, converted to other sugars or used to generate NADPH. The
substrate ATP is also an allosteric inhibitor of phosphofructokinase -
the enzyme of the major rate-limiting step of glycolysis. AMP, ADP and
F2,6P are activators (the concentration of the latter is the outcome of
its synthesis/degradation cycle mediated by Pfkfb members -
bifunctional enzymes that are heavily regulated). Phosphofructokinase is a
tetramer with two conformational states R and T that are in
equilibrium. The F6P substrate, the ATP substrate or inhibitor and the
activators modulate the level of enzyme activity via preferential
binding to the R or T state.
To see the ontology report for annotations, GViewer and download, click here. [Click to see the ontology report for associated GO term - GO:0006096 , related KEGG map
-
map00010 and entry at Reactome -
REACT_1383.5 ]
...(less)
Pathway Diagram:
GO TO:
Genes in Pathway:
Symbol
Object Name
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Acss1
acyl-CoA synthetase short-chain family member 1
IEA
KEGG
rno:00010
NCBI chr 3:159,910,809...159,960,748
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
IEA
KEGG
rno:00010
NCBI chr 3:164,464,124...164,507,607
Ensembl chr 3:144,004,336...144,059,675
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
IEA
KEGG
rno:00010
NCBI chr 2:229,622,092...229,640,120
Ensembl chr 2:226,947,466...226,987,591
G
Adh5
alcohol dehydrogenase 5 (class III), chi polypeptide
IEA
KEGG
rno:00010
NCBI chr 2:229,648,557...229,660,964
Ensembl chr 2:226,947,466...226,987,591
G
Adh6
alcohol dehydrogenase 6 (class V)
IEA
KEGG
rno:00010
NCBI chr 2:229,576,612...229,608,359
Ensembl chr 2:226,903,250...226,934,534
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
IEA
KEGG
rno:00010
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
G
Adpgk
ADP-dependent glucokinase
IEA
KEGG
rno:00010
NCBI chr 8:68,595,194...68,623,179
Ensembl chr 8:59,699,388...59,727,351
G
Akr1a1
aldo-keto reductase family 1 member A1
IEA
KEGG
rno:00010
NCBI chr 5:135,329,605...135,367,037
Ensembl chr 5:130,092,732...130,113,674
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
IEA
KEGG
rno:00010
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
IEA
KEGG
rno:00010
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:119,982,277...120,017,436
G
Aldh1a7
aldehyde dehydrogenase family 1, subfamily A7
IEA
KEGG
rno:00010
NCBI chr 1:227,627,977...227,667,877
Ensembl chr 1:218,201,472...218,248,906
G
Aldh1b1
aldehyde dehydrogenase 1 family, member B1
IEA
KEGG
rno:00010
NCBI chr 5:64,859,000...64,864,008
Ensembl chr 5:60,063,225...60,068,378
G
Aldh2
aldehyde dehydrogenase 2 family member
IEA
KEGG
rno:00010
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
IEA
KEGG
rno:00010
NCBI chr10:46,392,464...46,402,151
Ensembl chr10:45,892,924...45,902,681
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
IEA
KEGG
rno:00010
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:45,908,524...45,949,281
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
IEA
KEGG
rno:00010
NCBI chr 1:210,574,545...210,605,188
Ensembl chr 1:201,145,309...201,163,921
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
IEA
KEGG
rno:00010
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:50,009,934...50,042,193
G
Aldh9a1
aldehyde dehydrogenase 9 family, member A1
IEA
KEGG
rno:00010
NCBI chr13:82,038,679...82,055,478
Ensembl chr13:79,505,695...79,540,568
G
Aldoa
aldolase, fructose-bisphosphate A
ISO IEA
KEGG SMPDB RGD
PMID:5251864
SMP:00040 rno:00010, RGD:2302796
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:181,402,275...181,406,182
G
Aldoart2
aldolase 1 A retrogene 2
ISO
SMPDB RGD
PMID:5251864
RGD:2302796 SMP:00040
NCBI chr 6:72,939,821...72,941,511
Ensembl chr 6:72,939,788...72,941,709
G
Aldob
aldolase, fructose-bisphosphate B
ISO IEA
KEGG RGD
PMID:5251864
rno:00010, RGD:2302796
NCBI chr 5:68,684,541...68,697,582
Ensembl chr 5:63,889,046...63,902,116
G
Aldoc
aldolase, fructose-bisphosphate C
IEA
KEGG
rno:00010
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,217,451...63,221,066
G
Bpgm
bisphosphoglycerate mutase
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
G
Dlat
dihydrolipoamide S-acetyltransferase
IEA
KEGG
rno:00010
NCBI chr 8:59,875,537...59,900,947
Ensembl chr 8:50,978,051...51,004,479 Ensembl chr 1:50,978,051...51,004,479
G
Dld
dihydrolipoamide dehydrogenase
IEA
KEGG
rno:00010
NCBI chr 6:53,631,686...53,655,059
Ensembl chr 6:47,903,914...47,924,795
G
Eno1
enolase 1
ISO IEA
KEGG SMPDB RGD
PMID:18560153
SMP:00040 rno:00010, RGD:2302799
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Eno2
enolase 2
IEA
KEGG
rno:00010
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980
G
Eno3
enolase 3
IEA
KEGG
rno:00010
NCBI chr10:55,868,880...55,876,099
Ensembl chr10:55,366,975...55,375,921
G
Fbp1
fructose-bisphosphatase 1
IEA
KEGG
rno:00010
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,208,031...2,230,071
G
Fbp2
fructose-bisphosphatase 2
IEA
KEGG
rno:00010
NCBI chr17:2,241,767...2,259,371
Ensembl chr17:2,236,336...2,253,698
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,257,668...86,333,804
G
Galm
galactose mutarotase
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:14,837,548...14,889,310
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gapdh-ps118
Glyceraldehyde-3-phosphate dehydrogenase, pseudogene 118
IEA
KEGG
rno:00010
NCBI chr18:61,626,988...61,628,224
Ensembl chr 4:157,962,343...157,966,235
G
Gapdhl10
glyceraldehyde-3-phosphate dehydrogenase like 10
IEA
KEGG
rno:00010
NCBI chr16:15,370,290...15,371,300
Ensembl chr16:15,370,293...15,371,300
G
Gapdhl3
glyceraldehyde-3-phosphate dehydrogenase like 3
IEA
KEGG
rno:00010
NCBI chr15:77,324,675...77,471,131
G
Gapdhl9
glyceraldehyde-3-phosphate dehydrogenase like 9
IEA
KEGG
rno:00010
NCBI chr 2:210,784,633...210,785,652
G
Gapdhs
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
IEA
KEGG
rno:00010
NCBI chr 1:95,106,516...95,125,918
Ensembl chr 1:85,979,098...85,993,640
G
Gck
glucokinase
TAS IDA IEA
KEGG RGD
PMID:9540816 PMID:4273555 PMID:4353083
rno:00010, RGD:2302784 , RGD:2302790 , RGD:2302851
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
G
Gpi
glucose-6-phosphate isomerase
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:86,828,216...86,856,086
G
Hk1
hexokinase 1
TAS IDA IEA
KEGG RGD
PMID:9540816 PMID:4353083
rno:00010, RGD:2302784 , RGD:2302851
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131
G
Hk2
hexokinase 2
TAS IEA ISO
KEGG SMPDB RGD
PMID:9540816
SMP:00040 rno:00010, RGD:2302784
NCBI chr 4:116,792,258...116,841,275
Ensembl chr 4:115,234,509...115,283,530
G
Hk3
hexokinase 3
TAS IEA
KEGG RGD
PMID:9540816
rno:00010, RGD:2302784
NCBI chr17:9,602,119...9,620,038
Ensembl chr17:9,599,865...9,614,863
G
Ldha
lactate dehydrogenase A
IEA
KEGG
rno:00010
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Ldhal1
lactate dehydrogenase A like 1
IEA
KEGG
rno:00010
NCBI chr 8:30,363,220...30,364,836
G
Ldhal6b
lactate dehydrogenase A-like 6B
IEA
KEGG
rno:00010
NCBI chr 1:45,997,845...45,999,268
Ensembl chr 1:45,991,991...45,999,272
G
Ldhb
lactate dehydrogenase B
IEA
KEGG
rno:00010
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403
G
Ldhc
lactate dehydrogenase C
IEA
KEGG
rno:00010
NCBI chr 1:106,522,140...106,539,649
Ensembl chr 1:97,382,379...97,403,378
G
Pank1
pantothenate kinase 1
ISO
SMPDB
SMP:00040
NCBI chr 1:241,737,371...241,808,126
Ensembl chr 1:232,328,430...232,396,829
G
Pck1
phosphoenolpyruvate carboxykinase 1
IEA
KEGG
rno:00010
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
IEA
KEGG
rno:00010
NCBI chr15:32,997,853...33,006,691
Ensembl chr15:29,027,894...29,037,283
G
Pdha1
pyruvate dehydrogenase E1 subunit alpha 1
IEA
KEGG
rno:00010
NCBI chr X:38,509,158...38,522,986
Ensembl chr X:34,700,409...34,714,311
G
Pdha2
pyruvate dehydrogenase E1 subunit alpha 2
IEA
KEGG
rno:00010
NCBI chr 2:232,545,550...232,547,098
G
Pdhb
pyruvate dehydrogenase E1 subunit beta
IEA
KEGG
rno:00010
NCBI chr15:19,182,789...19,188,731
Ensembl chr15:16,750,980...16,758,500
G
Pfkfb1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
TAS
RGD
PMID:15170386
RGD:2302793
NCBI chr X:22,936,038...22,989,691
Ensembl chr X:19,508,546...19,562,182
G
Pfkfb2
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
TAS
RGD
PMID:15170386
RGD:2302793
NCBI chr13:44,683,499...44,727,135
Ensembl chr13:42,147,478...42,174,699
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
TAS
RGD
PMID:15170386
RGD:2302793
NCBI chr17:71,893,320...71,974,526
Ensembl chr17:66,983,686...67,063,125
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
TAS
RGD
PMID:15170386
RGD:2302793
NCBI chr 8:118,522,371...118,565,478
Ensembl chr 8:109,643,937...109,685,634
G
Pfkl
phosphofructokinase, liver type
TAS IDA IEA
KEGG RGD
PMID:2931076 PMID:4273555 PMID:4353083
rno:00010, RGD:2302736 , RGD:2302790 , RGD:2302851
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,664,272...10,686,315
G
Pfkm
phosphofructokinase, muscle
TAS IEA ISO
KEGG SMPDB RGD
PMID:2931076
SMP:00040 rno:00010, RGD:2302736
NCBI chr 7:131,100,684...131,138,250
Ensembl chr 7:129,221,653...129,259,192
G
Pfkp
phosphofructokinase, platelet
TAS IEA
KEGG RGD
PMID:2931076
rno:00010, RGD:2302736
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:63,729,780...63,794,018
G
Pgam1
phosphoglycerate mutase 1
ISO IEA
KEGG SMPDB RGD
PMID:18092946
SMP:00040 rno:00010, RGD:2302794
NCBI chr 1:250,673,152...250,680,762
Ensembl chr 1:240,723,920...240,738,452
G
Pgam2
phosphoglycerate mutase 2
ISO IEA
KEGG SMPDB RGD
PMID:18092946
SMP:00040 rno:00010, RGD:2302794
NCBI chr14:84,895,763...84,897,874
Ensembl chr14:80,681,776...80,683,940
G
Pgk1
phosphoglycerate kinase 1
IDA IMP IEA
KEGG RGD
PMID:6405813 PMID:3091090
rno:00010, RGD:2302859 , RGD:2302860
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:71,271,440...71,287,418
G
Pgk1l1
phosphoglycerate kinase 1 like 1
IEA
KEGG
rno:00010
NCBI chr 2:44,487,980...44,489,330
Ensembl chr 2:42,754,639...42,755,856
G
Pgk2
phosphoglycerate kinase 2
IEA
KEGG
rno:00010
NCBI chr 9:27,976,913...27,978,479
Ensembl chr 9:20,480,203...20,571,481
G
Pgm1
phosphoglucomutase 1
IEA
KEGG
rno:00010
NCBI chr 5:119,710,734...119,770,159
Ensembl chr 5:114,595,293...114,654,728
G
Pklr
pyruvate kinase L/R
IDA IEA ISO
KEGG SMPDB RGD
PMID:4273555 PMID:4353083
SMP:00040 rno:00010, RGD:2302790 , RGD:2302851
NCBI chr 2:176,840,779...176,849,637
Ensembl chr 2:174,543,039...174,551,870
G
Pkm
pyruvate kinase M1/2
IDA
RGD
PMID:4273555
RGD:2302790
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599
G
Slc2a2
solute carrier family 2 member 2
ISO
SMPDB
SMP:00040
NCBI chr 2:113,537,884...113,568,422
Ensembl chr 2:111,611,774...111,639,933
G
Tpi1
triosephosphate isomerase 1
IEA ISO
KEGG SMPDB
SMP:00040 rno:00010
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541
G
Tpi1l2
triosephosphate isomerase 1 like 2
IEA
KEGG
rno:00010
NCBI chr17:27,307,380...28,230,998
Ensembl chr17:27,101,431...27,102,809
Additional Elements in Pathway: (includes Gene Groups, Small Molecules, Other Pathways..etc.)
Functional Class Pfkfb members (kinase) members of the bifunctional elzyme that catalyzes the synthesis and degradation of F2,6P Functional Class Pfkfb members (phosphatase) members of the bifunctional elzyme that catalyzes the synthesis and degradation of F2,6P Functional Class aldolases the aldolase isozymes Functional Class enolases the enolase isozymes
Pathway Gene Annotations
Disease Annotations Associated with Genes in the glycolysis pathway
Acss1 Experimental Melanoma , Hypothermia Acss2 Experimental Melanoma , glutathione synthetase deficiency , glutatione synthetase deficiency with 5-oxoprolinuria , Inflammation , long QT syndrome , lymphangioleiomyomatosis , morbid obesity , orofacial cleft Adh4 alcohol dependence , autism spectrum disorder , Binge Drinking , Cluster Headache , Experimental Liver Cirrhosis , hepatocellular carcinoma , metabolic dysfunction-associated steatotic liver disease , Prenatal Exposure Delayed Effects Adh5 alcohol use disorder , AMED syndrome , asthma , autism spectrum disorder , cholestasis , pulmonary hypertension Adh6 autism spectrum disorder Adh7 Esophageal Neoplasms , Laryngeal Neoplasms , Mouth Neoplasms , Parkinson's disease , Pharyngeal Neoplasms Adpgk Bardet-Biedl syndrome , Bloom syndrome , Brugada syndrome 8 , colorectal cancer , schizophrenia , Tay-Sachs disease Akr1a1 autism spectrum disorder , breast cancer , Carcinogenesis , Charcot-Marie-Tooth disease dominant intermediate C , Chemical and Drug Induced Liver Injury , developmental and epileptic encephalopathy , early infantile epileptic encephalopathy , hepatocellular carcinoma , Kidney Reperfusion Injury , lung adenocarcinoma , perinatal necrotizing enterocolitis Aldh1a1 autism spectrum disorder , Creutzfeldt-Jakob disease , Experimental Liver Cirrhosis , liver disease , melanoma , metabolic dysfunction-associated steatotic liver disease , Neoplastic Cell Transformation , oral squamous cell carcinoma , pancreatic cancer , Parkinsonism , renal cell carcinoma Aldh1a3 autism spectrum disorder , autistic disorder , chromosome 15q26-qter deletion syndrome , genetic disease , isolated microphthalmia 8 , melanoma , microphthalmia , Neurodevelopmental Disorders , Stomach Neoplasms , syndromic microphthalmia 9 Aldh1a7 Hemorrhagic Shock Aldh1b1 cholestasis , Colonic Neoplasms , Experimental Liver Cirrhosis , Hepatomegaly , metabolic dysfunction-associated steatotic liver disease Aldh2 Acute Alcohol Sensitivity , alcohol dependence , alcohol use disorder , alcohol-induced mental disorder , alcoholic liver cirrhosis , Alcoholic Liver Diseases , Alzheimer's disease , AMED syndrome , asthma , autism spectrum disorder , brain infarction , Chemical and Drug Induced Liver Injury , Colorectal Neoplasms , Diabetes Complications , diabetic neuropathy , esophageal cancer , Esophageal Neoplasms , esophagus squamous cell carcinoma , Experimental Liver Cirrhosis , Flushing , Genetic Predisposition to Disease , heart disease , Heart Injuries , hepatocellular carcinoma , heroin dependence , hypertension , Insulin Resistance , Kidney Reperfusion Injury , liver cancer , liver disease , Liver Reperfusion Injury , male infertility , Melanosis , metabolic dysfunction and alcohol associated liver disease , metabolic dysfunction-associated steatotic liver disease , myocardial infarction , Myocardial Ischemia , Myocardial Reperfusion Injury , occupational dermatitis , pancreatic cancer , Parkinson's disease , perinatal necrotizing enterocolitis , pre-malignant neoplasm , Sepsis , type 1 diabetes mellitus , type 2 diabetes mellitus , vascular disease , Ventricular Dysfunction Aldh3a1 arteriosclerosis , autism spectrum disorder , autistic disorder , cataract , Corneal Injuries , keratoconus , Meckel Syndrome 9 , Potocki-Lupski syndrome Aldh3a2 autism spectrum disorder , autistic disorder , common variable immunodeficiency 2 , genetic disease , Joubert syndrome 1 , Meckel Syndrome 9 , Potocki-Lupski syndrome , Sjogren-Larsson syndrome Aldh3b1 Aicardi-Goutieres Syndrome 3 , autism spectrum disorder , immunodeficiency 90 , intellectual disability Aldh7a1 adult onset demyelinating leukodystrophy , benign neonatal seizures , bone disease , coloboma , developmental and epileptic encephalopathy 1 , developmental and epileptic encephalopathy 13 , Disease Progression , early-onset vitamin B6-dependent epilepsy 4 , epilepsy , familial adenomatous polyposis 1 , genetic disease , hepatocellular carcinoma , Hereditary Neoplastic Syndromes , hydrocephalus , intellectual disability , Leukoencephalopathies , Nervous System Malformations , Neurodevelopmental Disorders , pyridoxine-dependent epilepsy , Stomach Neoplasms , Ventriculomegaly , visual epilepsy Aldh9a1 Chemical and Drug Induced Liver Injury , COVID-19 , gastrointestinal stromal tumor , parathyroid carcinoma , prostate cancer Aldoa autism spectrum disorder , autistic disorder , Breast Neoplasms , chromosome 16p11.2 deletion syndrome, 593-kb , chromosome 16p11.2 duplication syndrome , coronin-1A deficiency , cystadenoma , dilated cardiomyopathy , Endotoxemia , Episodic Kinesigenic Dyskinesia , episodic kinesigenic dyskinesia 1 , genetic disease , Glycogen Storage Disease XII , hereditary fructose intolerance syndrome , lung adenocarcinoma , Metabolic Syndrome , Myocardial Ischemia , Neoplasm Invasiveness , Neoplasm Metastasis , Neurodevelopmental Disorders , Reperfusion Injury , schizophrenia , spondylocostal dysostosis 5 Aldoart2 autism spectrum disorder , autistic disorder , chromosome 16p11.2 deletion syndrome, 593-kb , chromosome 16p11.2 duplication syndrome , coronin-1A deficiency , cystadenoma , genetic disease , Glycogen Storage Disease XII , schizophrenia , spondylocostal dysostosis 5 Aldob autoimmune hepatitis , Chemical and Drug Induced Liver Injury , diabetes mellitus , Experimental Diabetes Mellitus , fructose-1,6-bisphosphatase deficiency , genetic disease , hereditary fructose intolerance syndrome , Hypoxia , intellectual disability , liver benign neoplasm , Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency , peritonitis , Stomach Neoplasms , type 2 diabetes mellitus Aldoc autoimmune disease of the nervous system , borna disease , hepatocellular carcinoma , Stroke Bpgm familial erythrocytosis 8 , pleomorphic xanthoastrocytoma Dlat ataxia telangiectasia , BH4-deficient hyperphenylalaninemia A , Carney-Stratakis syndrome , Chemical and Drug Induced Liver Injury , chromosome 11 partial duplication syndrome , congenital disorder of glycosylation Il , dilated cardiomyopathy 1II , genetic disease , intellectual disability , Myocardial Ischemia , prostate cancer , Pyruvate Dehydrogenase E2 Deficiency , Sleep Deprivation Dld Congenital Infantile Lactic Acidosis due to LAD Deficiency , genetic disease , Leigh disease , lissencephaly 5 , maple syrup urine disease , pleomorphic xanthoastrocytoma , pyruvate decarboxylase deficiency , Subacute Necrotizing Encephalopathy of Leigh, Infantile Eno1 Acute Coronary Syndrome , adenocarcinoma , Alzheimer's disease , Animal Disease Models , Animal Mammary Neoplasms , Breast Neoplasms , carcinoma , Chemical and Drug Induced Liver Injury , chromosome 1p36 deletion syndrome , COVID-19 , Esophageal Neoplasms , Experimental Mammary Neoplasms , hepatocellular carcinoma , hypertension , lung adenocarcinoma , lung non-small cell carcinoma , male infertility , Mouth Neoplasms , Neoplasm Invasiveness , Neurodevelopmental Disorders , osteoarthritis , osteoporosis , perinatal necrotizing enterocolitis , rheumatoid arthritis , squamous cell carcinoma , Stomach Neoplasms Eno2 acute myeloid leukemia , Atrophy , brain disease , Brain Injuries , breast carcinoma , Carcinoid Tumor , developmental and epileptic encephalopathy 21 , Endometrioid Carcinomas , Experimental Diabetes Mellitus , Experimental Liver Neoplasms , Experimental Neoplasms , Experimental Seizures , hereditary breast ovarian cancer syndrome , Hyperphosphatemic Familial Tumoral Calcinosis 1 , hypertension , Kidney Neoplasms , Klippel-Feil syndrome 3 , Lewy body dementia , lung non-small cell carcinoma , lymphoproliferative syndrome 2 , migraine without aura , Multiple Trauma , Neoplastic Cell Transformation , Nerve Tissue Neoplasms , neuroendocrine carcinoma , Parkinson's disease , Parkinsonism , peroxisome biogenesis disorder 2B , prostate cancer , Reperfusion Injury , Spinal Cord Injuries , Temtamy syndrome , toxic shock syndrome , urinary bladder cancer , Urologic Neoplasms Eno3 aortic valve stenosis , congenital myasthenic syndrome 4A , genetic disease , Glycogen Storage Disease XIII , liver disease , spastic ataxia 2 Fbp1 Acute Liver Failure , Baker-Winegrad Disease , Colonic Neoplasms , fructose-1,6-bisphosphatase deficiency , genetic disease , hepatocellular carcinoma , hiatus hernia , Parkinson's disease , schizophrenia , Stomach Neoplasms Fbp2 Acute Liver Failure , Childhood-Onset Remitting Leukodystrophy , fructose-1,6-bisphosphatase deficiency , hiatus hernia , Neurodevelopmental Disorders G6pc1 Chemical and Drug Induced Liver Injury , Dwarfism , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Fetal Growth Retardation , genetic disease , gestational diabetes , glycogen storage disease , glycogen storage disease I , glycogen storage disease Ia , hepatocellular carcinoma , hypoglycemia , Liver Failure , metabolic dysfunction-associated steatotic liver disease , Metabolic Syndrome , steatotic liver disease , type 2 diabetes mellitus Galm buphthalmos , galactosemia 4 , genetic disease , Lynch syndrome , RASopathy Gapdh Acute Coronary Syndrome , Alzheimer's disease , Animal Disease Models , brain glioma , Colorectal Neoplasms , COVID-19 , diabetic retinopathy , epilepsy , Esophageal Neoplasms , Experimental Diabetes Mellitus , hepatocellular carcinoma , Huntington's disease , Hyperphosphatemic Familial Tumoral Calcinosis 1 , Hypoxia , lung adenocarcinoma , lymphangioleiomyomatosis , lymphoproliferative syndrome 2 , middle cerebral artery infarction , Mouth Neoplasms , Myocardial Reperfusion Injury , Necrosis , obesity , oral squamous cell carcinoma , osteoarthritis , osteoporosis , Parkinsonism , peroxisome biogenesis disorder 2B , Pregnancy in Diabetics , primary autosomal recessive microcephaly 21 , rheumatic heart disease , Spinal Cord Injuries , Spinal Cord Reperfusion Injury , squamous cell carcinoma , Temtamy syndrome , type 2 diabetes mellitus , Viral Bronchiolitis Gapdhs Alzheimer's disease , Brugada syndrome 5 , dystonia , hereditary spastic paraplegia 75 , prostate cancer Gck Bone Marrow Failure Syndrome 2 , Congenital Hyperinsulinism , coronary artery disease , diabetes mellitus , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , familial hyperinsulinemic hypoglycemia 3 , genetic disease , gestational diabetes , hyperglycemia , hyperinsulinemic hypoglycemia , hyperinsulinism , hypertension , hypoglycemia , Insulin Resistance , Liver Injury , maturity-onset diabetes of the young , maturity-onset diabetes of the young type 1 , maturity-onset diabetes of the young type 2 , maturity-onset diabetes of the young type 3 , Metabolic Syndrome , neonatal diabetes mellitus , Nijmegen breakage syndrome , obesity , permanent neonatal diabetes mellitus , Permanent Neonatal Diabetes Mellitus 1 , pleomorphic xanthoastrocytoma , steatotic liver disease , transient neonatal diabetes mellitus , type 2 diabetes mellitus Gpi acute lymphoblastic leukemia , acute myeloid leukemia , Animal Disease Models , Breast Neoplasms , congenital hemolytic anemia , congenital nonspherocytic hemolytic anemia , congenital nonspherocytic hemolytic anemia 4 , Experimental Arthritis , genetic disease , hemolytic anemia , hereditary spastic paraplegia 75 , hereditary spherocytosis , intellectual disability , lung adenocarcinoma , Mental Retardation, Autosomal Recessive 42 , Neoplasm Metastasis , neuromuscular disease Hk1 acute lymphoblastic leukemia , anemia , Animal Disease Models , autism spectrum disorder , Charcot-Marie-Tooth disease type 4G , Chronic Intermittent Hypoxia , colorectal cancer , congenital nonspherocytic hemolytic anemia , congenital nonspherocytic hemolytic anemia 5 , COVID-19 , Experimental Diabetes Mellitus , fundus dystrophy , genetic disease , Hexokinase Deficiency Hemolytic Anemia , lung adenocarcinoma , macular degeneration , multiple myeloma , Myocardial Ischemia , NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES , Neurodevelopmental Disorders , obesity , pulmonary hypertension , retinitis pigmentosa , Retinitis Pigmentosa 79 , sickle cell anemia , type 2 diabetes mellitus , urinary bladder cancer Hk2 Animal Disease Models , Chronic Intermittent Hypoxia , hypertension , lung adenocarcinoma , Myocardial Ischemia , obesity , type 2 diabetes mellitus Hk3 Chromosome 5, Trisomy 5q , Ehlers-Danlos syndrome dermatosparaxis type , Ehlers-Danlos syndrome spondylodysplastic type 2 , liver disease , long QT syndrome , Marfanoid Mental Retardation Syndrome, Autosomal , Sotos syndrome Ldha Acute Liver Failure , Animal Disease Models , cardiomyopathy , COVID-19 , Experimental Neoplasms , Fanconi syndrome , Fanconi-Bickel syndrome , genetic disease , Glycogen Storage Disease XI , hyperglycemia , hypertension , hypertrophic cardiomyopathy 12 , intellectual disability , lung adenocarcinoma , myocardial infarction , myoglobinuria , pancreatic cancer , progressive myoclonus epilepsy 7 Ldhal6b Bloom syndrome , Breast Neoplasms , colorectal cancer , focal segmental glomerulosclerosis 6 Ldhb Acute Coronary Syndrome , Breast Neoplasms , dilated cardiomyopathy 1O , ductal carcinoma in situ , Experimental Liver Cirrhosis , inherited metabolic disorder , Lactate Dehydrogenase B Deficiency , Neoplasm Invasiveness , Prostatic Neoplasms , renal cell carcinoma Ldhc hypertrophic cardiomyopathy 12 , intellectual disability , lung disease , male infertility , progressive myoclonus epilepsy 7 Pank1 Nerve Degeneration Pck1 Alzheimer's disease , celiac disease , Chronic Intermittent Hypoxia , congestive heart failure , Endotoxemia , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Fetal Growth Retardation , genetic disease , hepatocellular carcinoma , hyperglycemia , metabolic dysfunction-associated steatohepatitis , Metabolic Syndrome , obesity , Phosphoenolpyruvate Carboxykinase Deficiency , Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic , type 2 diabetes mellitus Pck2 Brain-Lung-Thyroid Syndrome , COVID-19 , Endotoxemia , Experimental Liver Cirrhosis , Hypoxia , lysinuric protein intolerance , Phosphoenolpyruvate Carboxykinase Deficiency, Mitochondrial , retinitis pigmentosa 27 , Specific Granule Deficiency Pdha1 autistic disorder , Coffin-Lowry syndrome , developmental and epileptic encephalopathy 2 , Disease Progression , epilepsy , genetic disease , glycogen storage disease IXA , lactic acidosis , Leigh Syndrome, X-Linked , mitochondrial metabolism disease , Myocardial Ischemia , Nance-Horan syndrome , Neurodevelopmental Disorders , osteoarthritis , Prostatic Neoplasms , pyruvate decarboxylase deficiency , Pyruvate Dehydrogenase E1 Alpha Deficiency , Pyruvate Metabolism, Inborn Errors , Stomach Neoplasms , sudden infant death syndrome , syndromic X-linked intellectual disability Lubs type Pdha2 azoospermia , spermatogenic failure 1 , spermatogenic failure 70 Pdhb epilepsy , genetic disease , pyruvate decarboxylase deficiency , Pyruvate Dehydrogenase E1-Beta Deficiency , Pyruvate Dehydrogenase Phosphatase Deficiency , renal cell carcinoma Pfkfb1 autistic disorder , autosomal hemophilia A , Cornelia de Lange syndrome 2 , factor VIII deficiency , hyperinsulinism , syndromic X-linked intellectual disability Lubs type Pfkfb2 autistic disorder , common variable immunodeficiency 7 , gastrointestinal stromal tumor , Hypokalemic Periodic Paralysis, Type 1 , inflammatory bowel disease , parathyroid carcinoma Pfkfb3 Acute Lung Injury , Arsenic Poisoning , extrinsic cardiomyopathy , hypoparathyroidism-deafness-renal disease syndrome , Myocardial Ischemia , obesity , schizophrenia , skin disease Pfkfb4 Aicardi-Goutieres Syndrome 1 , Progressive Microcephaly with Seizures and Cerebral and Cerebellar Atrophy Pfkl autistic disorder , autoimmune polyendocrine syndrome type 1 , cataract 9 multiple types , developmental and epileptic encephalopathy 30 , homocystinuria , Neurodevelopmental Disorders , primary ciliary dyskinesia , progressive myoclonus epilepsy Pfkm Experimental Diabetes Mellitus , genetic disease , glycogen storage disease , glycogen storage disease IV , glycogen storage disease VII , Myocardial Ischemia , peroxisome biogenesis disorder 3B , Rhabdomyolysis Pfkp Experimental Liver Cirrhosis , schizophrenia , syndromic microphthalmia 5 Pgam1 adenocarcinoma , Animal Mammary Neoplasms , carcinoma , Experimental Mammary Neoplasms , lung non-small cell carcinoma , Mouth Neoplasms , squamous cell carcinoma , Stomach Neoplasms Pgam2 Dimauro Disease , genetic disease , myoglobinuria , pleomorphic xanthoastrocytoma , Prostatic Neoplasms , Rhabdomyolysis Pgk1 alpha thalassemia-X-linked intellectual disability syndrome , autistic disorder , autosomal hemophilia A , factor VIII deficiency , generalized epilepsy , genetic disease , hemolytic anemia , hepatocellular carcinoma , Menkes disease , optic atrophy , phosphoglycerate kinase 1 deficiency , renal cell carcinoma , syndromic X-linked intellectual disability Lubs type , X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia , Young Syndrome Pgm1 Chemical and Drug Induced Liver Injury , Colorectal Neoplasms , congenital disorder of glycosylation , congenital disorder of glycosylation It , Craniosynostosis Syndrome, Autosomal Recessive , endometrial cancer , genetic disease , intellectual disability , Myocardial Ischemia , teratoma Pklr Burns , Charcot-Marie-Tooth disease type 2 , congenital nonspherocytic hemolytic anemia , congenital nonspherocytic hemolytic anemia 2 , Elevated Adenosine Triphosphate of Erythrocytes , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , gastrointestinal stromal tumor , Gaucher's disease , genetic disease , hemolytic anemia , hyperglycemia , hyperinsulinism , Hypertriglyceridemia , immunodeficiency 42 , Insulin Resistance , malaria , metabolic dysfunction-associated steatotic liver disease , MHC class II deficiency , obesity , parathyroid carcinoma , Reperfusion Injury , severe congenital neutropenia 3 , severe congenital neutropenia 5 , type 2 diabetes mellitus Pkm Animal Mammary Neoplasms , Bloom syndrome , carcinoma , colorectal cancer , COVID-19 , Experimental Mammary Neoplasms , hepatocellular carcinoma , hypertension , lymphangioleiomyomatosis , Neoplasm Invasiveness , osteoporosis , Tay-Sachs disease Slc2a2 Breast Neoplasms , diabetes mellitus , Experimental Diabetes Mellitus , Fanconi syndrome , Fanconi-Bickel syndrome , Fetal Growth Retardation , gastrinoma , genetic disease , Glucagonoma , glycogen storage disease , hepatocellular carcinoma , insulinoma , long QT syndrome , maturity-onset diabetes of the young type 1 , neural tube defect , pancreatic ductal carcinoma , steatotic liver disease , type 2 diabetes mellitus Tpi1 Alzheimer's disease , Animal Disease Models , carbohydrate metabolic disorder , congenital nonspherocytic hemolytic anemia , COVID-19 , developmental and epileptic encephalopathy 21 , esophagus squamous cell carcinoma , Experimental Diabetes Mellitus , genetic disease , hemolytic anemia , Hyperphosphatemic Familial Tumoral Calcinosis 1 , inherited metabolic disorder , Klippel-Feil syndrome 3 , lung adenocarcinoma , lymphoproliferative syndrome 2 , Mouth Neoplasms , neuromuscular disease , Neuromuscular Manifestations , ocular hypertension , osteoporosis , peroxisome biogenesis disorder 2B , squamous cell carcinoma , Temtamy syndrome , triosephosphate isomerase deficiency
Acute Alcohol Sensitivity Aldh2 Acute Coronary Syndrome Eno1 , Gapdh , Ldhb Acute Liver Failure Fbp1 , Fbp2 , Ldha Acute Lung Injury Pfkfb3 acute lymphoblastic leukemia Gpi , Hk1 acute myeloid leukemia Eno2 , Gpi adenocarcinoma Eno1 , Pgam1 adult onset demyelinating leukodystrophy Aldh7a1 Aicardi-Goutieres Syndrome 1 Pfkfb4 Aicardi-Goutieres Syndrome 3 Aldh3b1 alcohol dependence Adh4 , Aldh2 alcohol use disorder Adh5 , Aldh2 alcohol-induced mental disorder Aldh2 alcoholic liver cirrhosis Aldh2 Alcoholic Liver Diseases Aldh2 alpha thalassemia-X-linked intellectual disability syndrome Pgk1 Alzheimer's disease Aldh2 , Eno1 , Gapdh , Gapdhs , Pck1 , Tpi1 AMED syndrome Adh5 , Aldh2 anemia Hk1 Animal Disease Models Eno1 , Gapdh , Gpi , Hk1 , Hk2 , Ldha , Tpi1 Animal Mammary Neoplasms Eno1 , Pgam1 , Pkm aortic valve stenosis Eno3 Arsenic Poisoning Pfkfb3 arteriosclerosis Aldh3a1 asthma Adh5 , Aldh2 ataxia telangiectasia Dlat Atrophy Eno2 autism spectrum disorder Adh4 , Adh5 , Adh6 , Akr1a1 , Aldh1a1 , Aldh1a3 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldoa , Aldoart2 , Hk1 autistic disorder Aldh1a3 , Aldh3a1 , Aldh3a2 , Aldoa , Aldoart2 , Pdha1 , Pfkfb1 , Pfkfb2 , Pfkl , Pgk1 autoimmune disease of the nervous system Aldoc autoimmune hepatitis Aldob autoimmune polyendocrine syndrome type 1 Pfkl autosomal hemophilia A Pfkfb1 , Pgk1 azoospermia Pdha2 Baker-Winegrad Disease Fbp1 Bardet-Biedl syndrome Adpgk benign neonatal seizures Aldh7a1 BH4-deficient hyperphenylalaninemia A Dlat Binge Drinking Adh4 Bloom syndrome Adpgk , Ldhal6b , Pkm bone disease Aldh7a1 Bone Marrow Failure Syndrome 2 Gck borna disease Aldoc brain disease Eno2 brain glioma Gapdh brain infarction Aldh2 Brain Injuries Eno2 Brain-Lung-Thyroid Syndrome Pck2 breast cancer Akr1a1 breast carcinoma Eno2 Breast Neoplasms Aldoa , Eno1 , Gpi , Ldhal6b , Ldhb , Slc2a2 Brugada syndrome 5 Gapdhs Brugada syndrome 8 Adpgk buphthalmos Galm Burns Pklr carbohydrate metabolic disorder Tpi1 Carcinogenesis Akr1a1 Carcinoid Tumor Eno2 carcinoma Eno1 , Pgam1 , Pkm cardiomyopathy Ldha Carney-Stratakis syndrome Dlat cataract Aldh3a1 cataract 9 multiple types Pfkl celiac disease Pck1 Charcot-Marie-Tooth disease dominant intermediate C Akr1a1 Charcot-Marie-Tooth disease type 2 Pklr Charcot-Marie-Tooth disease type 4G Hk1 Chemical and Drug Induced Liver Injury Akr1a1 , Aldh2 , Aldh9a1 , Aldob , Dlat , Eno1 , G6pc1 , Pgm1 Childhood-Onset Remitting Leukodystrophy Fbp2 cholestasis Adh5 , Aldh1b1 chromosome 11 partial duplication syndrome Dlat chromosome 15q26-qter deletion syndrome Aldh1a3 chromosome 16p11.2 deletion syndrome, 593-kb Aldoa , Aldoart2 chromosome 16p11.2 duplication syndrome Aldoa , Aldoart2 chromosome 1p36 deletion syndrome Eno1 Chromosome 5, Trisomy 5q Hk3 Chronic Intermittent Hypoxia Hk1 , Hk2 , Pck1 Cluster Headache Adh4 Coffin-Lowry syndrome Pdha1 coloboma Aldh7a1 Colonic Neoplasms Aldh1b1 , Fbp1 colorectal cancer Adpgk , Hk1 , Ldhal6b , Pkm Colorectal Neoplasms Aldh2 , Gapdh , Pgm1 common variable immunodeficiency 2 Aldh3a2 common variable immunodeficiency 7 Pfkfb2 congenital disorder of glycosylation Pgm1 congenital disorder of glycosylation Il Dlat congenital disorder of glycosylation It Pgm1 congenital hemolytic anemia Gpi Congenital Hyperinsulinism Gck Congenital Infantile Lactic Acidosis due to LAD Deficiency Dld congenital myasthenic syndrome 4A Eno3 congenital nonspherocytic hemolytic anemia Gpi , Hk1 , Pklr , Tpi1 congenital nonspherocytic hemolytic anemia 2 Pklr congenital nonspherocytic hemolytic anemia 4 Gpi congenital nonspherocytic hemolytic anemia 5 Hk1 congestive heart failure Pck1 Corneal Injuries Aldh3a1 Cornelia de Lange syndrome 2 Pfkfb1 coronary artery disease Gck coronin-1A deficiency Aldoa , Aldoart2 COVID-19 Aldh9a1 , Eno1 , Gapdh , Hk1 , Ldha , Pck2 , Pkm , Tpi1 Craniosynostosis Syndrome, Autosomal Recessive Pgm1 Creutzfeldt-Jakob disease Aldh1a1 cystadenoma Aldoa , Aldoart2 developmental and epileptic encephalopathy Akr1a1 developmental and epileptic encephalopathy 1 Aldh7a1 developmental and epileptic encephalopathy 13 Aldh7a1 developmental and epileptic encephalopathy 2 Pdha1 developmental and epileptic encephalopathy 21 Eno2 , Tpi1 developmental and epileptic encephalopathy 30 Pfkl Diabetes Complications Aldh2 diabetes mellitus Aldob , Gck , Slc2a2 diabetic neuropathy Aldh2 diabetic retinopathy Gapdh dilated cardiomyopathy Aldoa dilated cardiomyopathy 1II Dlat dilated cardiomyopathy 1O Ldhb Dimauro Disease Pgam2 Disease Progression Aldh7a1 , Pdha1 ductal carcinoma in situ Ldhb Dwarfism G6pc1 dystonia Gapdhs early infantile epileptic encephalopathy Akr1a1 early-onset vitamin B6-dependent epilepsy 4 Aldh7a1 Ehlers-Danlos syndrome dermatosparaxis type Hk3 Ehlers-Danlos syndrome spondylodysplastic type 2 Hk3 Elevated Adenosine Triphosphate of Erythrocytes Pklr endometrial cancer Pgm1 Endometrioid Carcinomas Eno2 Endotoxemia Aldoa , Pck1 , Pck2 epilepsy Aldh7a1 , Gapdh , Pdha1 , Pdhb Episodic Kinesigenic Dyskinesia Aldoa episodic kinesigenic dyskinesia 1 Aldoa esophageal cancer Aldh2 Esophageal Neoplasms Adh7 , Aldh2 , Eno1 , Gapdh esophagus squamous cell carcinoma Aldh2 , Tpi1 Experimental Arthritis Gpi Experimental Diabetes Mellitus Aldob , Eno2 , G6pc1 , Gapdh , Gck , Hk1 , Pck1 , Pfkm , Pklr , Slc2a2 , Tpi1 Experimental Liver Cirrhosis Adh4 , Aldh1a1 , Aldh1b1 , Aldh2 , G6pc1 , Gck , Ldhb , Pck1 , Pck2 , Pfkp , Pklr Experimental Liver Neoplasms Eno2 Experimental Mammary Neoplasms Eno1 , Pgam1 , Pkm Experimental Melanoma Acss1 , Acss2 Experimental Neoplasms Eno2 , Ldha Experimental Seizures Eno2 extrinsic cardiomyopathy Pfkfb3 factor VIII deficiency Pfkfb1 , Pgk1 familial adenomatous polyposis 1 Aldh7a1 familial erythrocytosis 8 Bpgm familial hyperinsulinemic hypoglycemia 3 Gck Fanconi syndrome Ldha , Slc2a2 Fanconi-Bickel syndrome Ldha , Slc2a2 Fetal Growth Retardation G6pc1 , Pck1 , Slc2a2 Flushing Aldh2 focal segmental glomerulosclerosis 6 Ldhal6b fructose-1,6-bisphosphatase deficiency Aldob , Fbp1 , Fbp2 fundus dystrophy Hk1 galactosemia 4 Galm gastrinoma Slc2a2 gastrointestinal stromal tumor Aldh9a1 , Pfkfb2 , Pklr Gaucher's disease Pklr generalized epilepsy Pgk1 genetic disease Aldh1a3 , Aldh3a2 , Aldh7a1 , Aldoa , Aldoart2 , Aldob , Dlat , Dld , Eno3 , Fbp1 , G6pc1 , Galm , Gck , Gpi , Hk1 , Ldha , Pck1 , Pdha1 , Pdhb , Pfkm , Pgam2 , Pgk1 , Pgm1 , Pklr , Slc2a2 , Tpi1 Genetic Predisposition to Disease Aldh2 gestational diabetes G6pc1 , Gck Glucagonoma Slc2a2 glutathione synthetase deficiency Acss2 glutatione synthetase deficiency with 5-oxoprolinuria Acss2 glycogen storage disease G6pc1 , Pfkm , Slc2a2 glycogen storage disease I G6pc1 glycogen storage disease Ia G6pc1 glycogen storage disease IV Pfkm glycogen storage disease IXA Pdha1 glycogen storage disease VII Pfkm Glycogen Storage Disease XI Ldha Glycogen Storage Disease XII Aldoa , Aldoart2 Glycogen Storage Disease XIII Eno3 heart disease Aldh2 Heart Injuries Aldh2 hemolytic anemia Gpi , Pgk1 , Pklr , Tpi1 Hemorrhagic Shock Aldh1a7 hepatocellular carcinoma Adh4 , Akr1a1 , Aldh2 , Aldh7a1 , Aldoc , Eno1 , Fbp1 , G6pc1 , Gapdh , Pck1 , Pgk1 , Pkm , Slc2a2 Hepatomegaly Aldh1b1 hereditary breast ovarian cancer syndrome Eno2 hereditary fructose intolerance syndrome Aldoa , Aldob Hereditary Neoplastic Syndromes Aldh7a1 hereditary spastic paraplegia 75 Gapdhs , Gpi hereditary spherocytosis Gpi heroin dependence Aldh2 Hexokinase Deficiency Hemolytic Anemia Hk1 hiatus hernia Fbp1 , Fbp2 homocystinuria Pfkl Huntington's disease Gapdh hydrocephalus Aldh7a1 hyperglycemia Gck , Ldha , Pck1 , Pklr hyperinsulinemic hypoglycemia Gck hyperinsulinism Gck , Pfkfb1 , Pklr Hyperphosphatemic Familial Tumoral Calcinosis 1 Eno2 , Gapdh , Tpi1 hypertension Aldh2 , Eno1 , Eno2 , Gck , Hk2 , Ldha , Pkm Hypertriglyceridemia Pklr hypertrophic cardiomyopathy 12 Ldha , Ldhc hypoglycemia G6pc1 , Gck Hypokalemic Periodic Paralysis, Type 1 Pfkfb2 hypoparathyroidism-deafness-renal disease syndrome Pfkfb3 Hypothermia Acss1 Hypoxia Aldob , Gapdh , Pck2 immunodeficiency 42 Pklr immunodeficiency 90 Aldh3b1 Inflammation Acss2 inflammatory bowel disease Pfkfb2 inherited metabolic disorder Ldhb , Tpi1 Insulin Resistance Aldh2 , Gck , Pklr insulinoma Slc2a2 intellectual disability Aldh3b1 , Aldh7a1 , Aldob , Dlat , Gpi , Ldha , Ldhc , Pgm1 isolated microphthalmia 8 Aldh1a3 Joubert syndrome 1 Aldh3a2 keratoconus Aldh3a1 Kidney Neoplasms Eno2 Kidney Reperfusion Injury Akr1a1 , Aldh2 Klippel-Feil syndrome 3 Eno2 , Tpi1 Lactate Dehydrogenase B Deficiency Ldhb lactic acidosis Pdha1 Laryngeal Neoplasms Adh7 Leigh disease Dld Leigh Syndrome, X-Linked Pdha1 Leukoencephalopathies Aldh7a1 Lewy body dementia Eno2 lissencephaly 5 Dld liver benign neoplasm Aldob liver cancer Aldh2 liver disease Aldh1a1 , Aldh2 , Eno3 , Hk3 Liver Failure G6pc1 Liver Injury Gck Liver Reperfusion Injury Aldh2 long QT syndrome Acss2 , Hk3 , Slc2a2 Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Aldob lung adenocarcinoma Akr1a1 , Aldoa , Eno1 , Gapdh , Gpi , Hk1 , Hk2 , Ldha , Tpi1 lung disease Ldhc lung non-small cell carcinoma Eno1 , Eno2 , Pgam1 lymphangioleiomyomatosis Acss2 , Gapdh , Pkm lymphoproliferative syndrome 2 Eno2 , Gapdh , Tpi1 Lynch syndrome Galm lysinuric protein intolerance Pck2 macular degeneration Hk1 malaria Pklr male infertility Aldh2 , Eno1 , Ldhc maple syrup urine disease Dld Marfanoid Mental Retardation Syndrome, Autosomal Hk3 maturity-onset diabetes of the young Gck maturity-onset diabetes of the young type 1 Gck , Slc2a2 maturity-onset diabetes of the young type 2 Gck maturity-onset diabetes of the young type 3 Gck Meckel Syndrome 9 Aldh3a1 , Aldh3a2 melanoma Aldh1a1 , Aldh1a3 Melanosis Aldh2 Menkes disease Pgk1 Mental Retardation, Autosomal Recessive 42 Gpi metabolic dysfunction and alcohol associated liver disease Aldh2 metabolic dysfunction-associated steatohepatitis Pck1 metabolic dysfunction-associated steatotic liver disease Adh4 , Aldh1a1 , Aldh1b1 , Aldh2 , G6pc1 , Pklr Metabolic Syndrome Aldoa , G6pc1 , Gck , Pck1 MHC class II deficiency Pklr microphthalmia Aldh1a3 middle cerebral artery infarction Gapdh migraine without aura Eno2 mitochondrial metabolism disease Pdha1 morbid obesity Acss2 Mouth Neoplasms Adh7 , Eno1 , Gapdh , Pgam1 , Tpi1 multiple myeloma Hk1 Multiple Trauma Eno2 myocardial infarction Aldh2 , Ldha Myocardial Ischemia Aldh2 , Aldoa , Dlat , Hk1 , Hk2 , Pdha1 , Pfkfb3 , Pfkm , Pgm1 Myocardial Reperfusion Injury Aldh2 , Gapdh myoglobinuria Ldha , Pgam2 Nance-Horan syndrome Pdha1 Necrosis Gapdh neonatal diabetes mellitus Gck Neoplasm Invasiveness Aldoa , Eno1 , Ldhb , Pkm Neoplasm Metastasis Aldoa , Gpi Neoplastic Cell Transformation Aldh1a1 , Eno2 Nerve Degeneration Pank1 Nerve Tissue Neoplasms Eno2 Nervous System Malformations Aldh7a1 neural tube defect Slc2a2 NEURODEVELOPMENTAL DISORDER WITH VISUAL DEFECTS AND BRAIN ANOMALIES Hk1 Neurodevelopmental Disorders Aldh1a3 , Aldh7a1 , Aldoa , Eno1 , Fbp2 , Hk1 , Pdha1 , Pfkl neuroendocrine carcinoma Eno2 neuromuscular disease Gpi , Tpi1 Neuromuscular Manifestations Tpi1 Nijmegen breakage syndrome Gck obesity Gapdh , Gck , Hk1 , Hk2 , Pck1 , Pfkfb3 , Pklr occupational dermatitis Aldh2 ocular hypertension Tpi1 optic atrophy Pgk1 oral squamous cell carcinoma Aldh1a1 , Gapdh orofacial cleft Acss2 osteoarthritis Eno1 , Gapdh , Pdha1 osteoporosis Eno1 , Gapdh , Pkm , Tpi1 pancreatic cancer Aldh1a1 , Aldh2 , Ldha pancreatic ductal carcinoma Slc2a2 parathyroid carcinoma Aldh9a1 , Pfkfb2 , Pklr Parkinson's disease Adh7 , Aldh2 , Eno2 , Fbp1 Parkinsonism Aldh1a1 , Eno2 , Gapdh perinatal necrotizing enterocolitis Akr1a1 , Aldh2 , Eno1 peritonitis Aldob permanent neonatal diabetes mellitus Gck Permanent Neonatal Diabetes Mellitus 1 Gck peroxisome biogenesis disorder 2B Eno2 , Gapdh , Tpi1 peroxisome biogenesis disorder 3B Pfkm Pharyngeal Neoplasms Adh7 Phosphoenolpyruvate Carboxykinase Deficiency Pck1 Phosphoenolpyruvate Carboxykinase Deficiency, Cytosolic Pck1 Phosphoenolpyruvate Carboxykinase Deficiency, Mitochondrial Pck2 phosphoglycerate kinase 1 deficiency Pgk1 pleomorphic xanthoastrocytoma Bpgm , Dld , Gck , Pgam2 Potocki-Lupski syndrome Aldh3a1 , Aldh3a2 pre-malignant neoplasm Aldh2 Pregnancy in Diabetics Gapdh Prenatal Exposure Delayed Effects Adh4 primary autosomal recessive microcephaly 21 Gapdh primary ciliary dyskinesia Pfkl Progressive Microcephaly with Seizures and Cerebral and Cerebellar Atrophy Pfkfb4 progressive myoclonus epilepsy Pfkl progressive myoclonus epilepsy 7 Ldha , Ldhc prostate cancer Aldh9a1 , Dlat , Eno2 , Gapdhs Prostatic Neoplasms Ldhb , Pdha1 , Pgam2 pulmonary hypertension Adh5 , Hk1 pyridoxine-dependent epilepsy Aldh7a1 pyruvate decarboxylase deficiency Dld , Pdha1 , Pdhb Pyruvate Dehydrogenase E1 Alpha Deficiency Pdha1 Pyruvate Dehydrogenase E1-Beta Deficiency Pdhb Pyruvate Dehydrogenase E2 Deficiency Dlat Pyruvate Dehydrogenase Phosphatase Deficiency Pdhb Pyruvate Metabolism, Inborn Errors Pdha1 RASopathy Galm renal cell carcinoma Aldh1a1 , Ldhb , Pdhb , Pgk1 Reperfusion Injury Aldoa , Eno2 , Pklr retinitis pigmentosa Hk1 retinitis pigmentosa 27 Pck2 Retinitis Pigmentosa 79 Hk1 Rhabdomyolysis Pfkm , Pgam2 rheumatic heart disease Gapdh rheumatoid arthritis Eno1 schizophrenia Adpgk , Aldoa , Aldoart2 , Fbp1 , Pfkfb3 , Pfkp Sepsis Aldh2 severe congenital neutropenia 3 Pklr severe congenital neutropenia 5 Pklr sickle cell anemia Hk1 Sjogren-Larsson syndrome Aldh3a2 skin disease Pfkfb3 Sleep Deprivation Dlat Sotos syndrome Hk3 spastic ataxia 2 Eno3 Specific Granule Deficiency Pck2 spermatogenic failure 1 Pdha2 spermatogenic failure 70 Pdha2 Spinal Cord Injuries Eno2 , Gapdh Spinal Cord Reperfusion Injury Gapdh spondylocostal dysostosis 5 Aldoa , Aldoart2 squamous cell carcinoma Eno1 , Gapdh , Pgam1 , Tpi1 steatotic liver disease G6pc1 , Gck , Slc2a2 Stomach Neoplasms Aldh1a3 , Aldh7a1 , Aldob , Eno1 , Fbp1 , Pdha1 , Pgam1 Stroke Aldoc Subacute Necrotizing Encephalopathy of Leigh, Infantile Dld sudden infant death syndrome Pdha1 syndromic microphthalmia 5 Pfkp syndromic microphthalmia 9 Aldh1a3 syndromic X-linked intellectual disability Lubs type Pdha1 , Pfkfb1 , Pgk1 Tay-Sachs disease Adpgk , Pkm Temtamy syndrome Eno2 , Gapdh , Tpi1 teratoma Pgm1 toxic shock syndrome Eno2 transient neonatal diabetes mellitus Gck triosephosphate isomerase deficiency Tpi1 type 1 diabetes mellitus Aldh2 type 2 diabetes mellitus Aldh2 , Aldob , G6pc1 , Gapdh , Gck , Hk1 , Hk2 , Pck1 , Pklr , Slc2a2 urinary bladder cancer Eno2 , Hk1 Urologic Neoplasms Eno2 vascular disease Aldh2 Ventricular Dysfunction Aldh2 Ventriculomegaly Aldh7a1 Viral Bronchiolitis Gapdh visual epilepsy Aldh7a1 X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia Pgk1 Young Syndrome Pgk1
Pathway Annotations Associated with Genes in the glycolysis pathway
Acss1 disulfiram pharmacodynamics pathway , fatty acid beta degradation pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , malonic aciduria pathway , methylmalonic aciduria, cobalamin-related pathway , propanoate metabolic pathway , pyruvate metabolic pathway Acss2 disulfiram pharmacodynamics pathway , fatty acid beta degradation pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , Leigh disease pathway , primary hyperoxaluria type 2 pathway , propanoate metabolic pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway Adh4 fatty acid metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phase I biotransformation pathway via cytochrome P450 , retinol metabolic pathway , tyrosine metabolic pathway Adh5 fatty acid metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phase I biotransformation pathway via cytochrome P450 , retinol metabolic pathway , tyrosine metabolic pathway Adh6 fatty acid metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phase I biotransformation pathway via cytochrome P450 , retinol metabolic pathway , tyrosine metabolic pathway Adh7 fatty acid metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phase I biotransformation pathway via cytochrome P450 , retinol metabolic pathway , tyrosine metabolic pathway Adpgk gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Akr1a1 doxorubicin pharmacokinetics pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , prostaglandin biosynthetic pathway Aldh1a1 arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , cyclophosphamide pharmacodynamics pathway , cyclophosphamide pharmacokinetics pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , ifosfamide pharmacodynamics pathway , ifosfamide pharmacokinetics pathway , lysine degradation pathway , neviparine pharmacokinetics pathway , pentose and glucuronate interconversion pathway , propanoate metabolic pathway , pyruvate metabolic pathway , retinoic acid metabolic pathway , retinol metabolic pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway , vitamin A deficiency pathway Aldh1a3 beta-alanine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , phase I biotransformation pathway via cytochrome P450 , phenylalanine metabolic pathway , retinoic acid metabolic pathway , tyrosine metabolic pathway Aldh1a7 arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , lysine degradation pathway , pentose and glucuronate interconversion pathway , propanoate metabolic pathway , pyruvate metabolic pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldh1b1 arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , disulfiram pharmacodynamics pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , lysine degradation pathway , pentose and glucuronate interconversion pathway , propanoate metabolic pathway , pyruvate metabolic pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldh2 3-hydroxy-3-methylglutaryl-CoA lyase deficiency pathway , 3-hydroxyisobutyric aciduria pathway , 3-methylcrotonyl CoA carboxylase 1 deficiency pathway , 3-methylglutaconic aciduria type 1 pathway , 3-methylglutaconic aciduria type 3 pathway , arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , carnosinemia pathway , dihydropyrimidine dehydrogenase deficiency pathway , dimethylglycine dehydrogenase deficiency pathway , disulfiram pharmacodynamics pathway , fatty acid metabolic pathway , GABA aminotransferase deficiency pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , histidinemia pathway , isobutyryl-CoA dehydrogenase deficiency pathway , isovaleric acidemia pathway , Leigh disease pathway , lysine degradation pathway , maple syrup urine disease pathway , methylmalonate semialdehyde dehydrogenase deficiency pathway , methylmalonic acidemia pathway , nonketotic hyperglycinemia pathway , pentose and glucuronate interconversion pathway , primary hyperoxaluria type 2 pathway , propanoate metabolic pathway , propionic acidemia pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , sarcosinemia pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldh3a1 alkaptonuria pathway , beta-alanine metabolic pathway , cyclophosphamide pharmacodynamics pathway , cyclophosphamide pharmacokinetics pathway , D-glycericacidemia pathway , disulfiram pharmacodynamics pathway , dopamine beta-hydroxylase deficiency pathway , familial lipoprotein lipase deficiency pathway , felbamate pharmacokinetics pathway , gluconeogenesis pathway , glycerol kinase deficiency pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hawkinsinuria pathway , histidine metabolic pathway , histidinemia pathway , ifosfamide pharmacodynamics pathway , ifosfamide pharmacokinetics pathway , phase I biotransformation pathway via cytochrome P450 , phenylalanine metabolic pathway , tyrosine metabolic pathway , tyrosinemia type I pathway Aldh3a2 arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , lysine degradation pathway , pentose and glucuronate interconversion pathway , phytanic acid degradation pathway , propanoate metabolic pathway , pyruvate metabolic pathway , Refsum disease pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldh3b1 beta-alanine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , phase I biotransformation pathway via cytochrome P450 , phenylalanine metabolic pathway , tyrosine metabolic pathway Aldh7a1 2-aminoadipic 2-oxoadipic aciduria pathway , arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , choline metabolic pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glutaric aciduria type I pathway , glycerolipid metabolic pathway , glycine, serine and threonine metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , hyperlysinemia pathway , lysine biosynthetic pathway , lysine degradation pathway , propanoate metabolic pathway , pyruvate metabolic pathway , remethylation pathway of homocysteine metabolism - cobalamin independent, betaine dependent , saccharopinuria pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldh9a1 arginine and proline metabolic pathway , ascorbate and aldarate metabolic pathway , beta-alanine metabolic pathway , carnitine biosynthetic pathway , fatty acid metabolic pathway , gluconeogenesis pathway , glycerolipid metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , histidine metabolic pathway , lysine degradation pathway , propanoate metabolic pathway , pyruvate metabolic pathway , tryptophan metabolic pathway , valine, leucine and isoleucine degradation pathway Aldoa Fanconi syndrome pathway , fructose and mannose metabolic pathway , fructose-1,6-bisphosphatase deficiency pathway , fructosuria pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , hypoxia inducible factor pathway , pentose phosphate pathway , phosphoenolpyruvate carboxykinase deficiency pathway , ribose 5-phosphate isomerase deficiency pathway , transaldolase deficiency pathway , triosephosphate isomerase deficiency pathway Aldoart2 Fanconi syndrome pathway , fructose and mannose metabolic pathway , fructose-1,6-bisphosphatase deficiency pathway , fructosuria pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , hereditary fructose intolerance syndrome pathway , hypoxia inducible factor pathway , pentose phosphate pathway , phosphoenolpyruvate carboxykinase deficiency pathway , ribose 5-phosphate isomerase deficiency pathway , transaldolase deficiency pathway , triosephosphate isomerase deficiency pathway Aldob forkhead class A signaling pathway , fructose and mannose metabolic pathway , fructosuria pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , pentose phosphate pathway Aldoc fructose and mannose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , pentose phosphate pathway Bpgm Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Dlat citric acid cycle pathway , fumaric aciduria pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , Leigh disease pathway , mitochondrial complex II deficiency pathway , primary hyperoxaluria type 2 pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate dehydrogenase E2 deficiency pathway , pyruvate dehydrogenase E3 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway Dld 2-aminoadipic 2-oxoadipic aciduria pathway , 3-hydroxy-3-methylglutaryl-CoA lyase deficiency pathway , 3-hydroxyisobutyric aciduria pathway , 3-methylcrotonyl CoA carboxylase 1 deficiency pathway , 3-methylglutaconic aciduria type 1 pathway , 3-methylglutaconic aciduria type 3 pathway , citric acid cycle pathway , dihydropyrimidine dehydrogenase deficiency pathway , dimethylglycine dehydrogenase deficiency pathway , folate cycle metabolic pathway , fumaric aciduria pathway , gluconeogenesis pathway , glutaric aciduria type I pathway , glycine, serine and threonine metabolic pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hyperlysinemia pathway , isobutyryl-CoA dehydrogenase deficiency pathway , isovaleric acidemia pathway , Leigh disease pathway , lysine degradation pathway , malonic aciduria pathway , maple syrup urine disease pathway , methylmalonate semialdehyde dehydrogenase deficiency pathway , methylmalonic acidemia pathway , methylmalonic aciduria, cobalamin-related pathway , mitochondrial complex II deficiency pathway , nonketotic hyperglycinemia pathway , primary hyperoxaluria type 2 pathway , propanoate metabolic pathway , propionic acidemia pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate dehydrogenase E2 deficiency pathway , pyruvate dehydrogenase E3 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , saccharopinuria pathway , sarcosinemia pathway , valine, leucine and isoleucine degradation pathway Eno1 Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , Notch signaling pathway , phosphoenolpyruvate carboxykinase deficiency pathway , RNA degradation pathway , triosephosphate isomerase deficiency pathway Eno2 gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , RNA degradation pathway Eno3 gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , RNA degradation pathway Fbp1 fructose and mannose metabolic pathway , fructose-1,6-bisphosphatase deficiency pathway , fructosuria pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , insulin signaling pathway , pentose phosphate pathway , phosphoenolpyruvate carboxykinase deficiency pathway , ribose 5-phosphate isomerase deficiency pathway , transaldolase deficiency pathway , triosephosphate isomerase deficiency pathway Fbp2 fructose and mannose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , pentose phosphate pathway G6pc1 altered galactose metabolic pathway , Fanconi syndrome pathway , forkhead class A signaling pathway , fructose-1,6-bisphosphatase deficiency pathway , galactose metabolic pathway , galactosemia pathway , gluconeogenesis pathway , Glut1 deficiency syndrome pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , lactose biosynthetic pathway , phosphoenolpyruvate carboxykinase deficiency pathway , starch and sucrose metabolic pathway , triosephosphate isomerase deficiency pathway Galm Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Gapdh Alzheimer's disease pathway , electron transport chain pathway , Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , nicotinamide adenine dinucleotide metabolic pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Gapdh-ps118 Alzheimer's disease pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Gapdhl10 Alzheimer's disease pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Gapdhl3 Alzheimer's disease pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Gapdhl9 Alzheimer's disease pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Gapdhs gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Gck amino sugar metabolic pathway , butirosin and neomycin biosynthetic pathway , congenital sucrase-isomaltase deficiency pathway , forkhead class A signaling pathway , galactokinase deficiency pathway , galactose metabolic pathway , galactosemia pathway , GALE deficiency pathway , gluconeogenesis pathway , glycogen biosynthetic pathway , glycogen metabolic pathway , glycogen storage disease type III pathway , glycogen storage disease type IV pathway , glycogen storage disease type VI pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , insulin secretion pathway , insulin signaling pathway , maturity-onset diabetes of the young pathway , nucleotide sugar metabolic pathway , starch and sucrose metabolic pathway , trehalose degradation pathway , type 2 diabetes mellitus pathway Gpi amino sugar metabolic pathway , congenital sucrase-isomaltase deficiency pathway , Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type III pathway , glycogen storage disease type IV pathway , glycogen storage disease type VI pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hexosamine biosynthetic pathway , nucleotide sugar metabolic pathway , pentose phosphate pathway , phosphoenolpyruvate carboxykinase deficiency pathway , ribose 5-phosphate isomerase deficiency pathway , starch and sucrose metabolic pathway , transaldolase deficiency pathway , triosephosphate isomerase deficiency pathway Hk1 amino sugar metabolic pathway , butirosin and neomycin biosynthetic pathway , french type sialuria pathway , fructose and mannose metabolic pathway , fructosuria pathway , galactose metabolic pathway , galactosemia pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , hypoxia inducible factor pathway , insulin signaling pathway , nucleotide sugar metabolic pathway , sialic acid storage disease pathway , starch and sucrose metabolic pathway , Tay-Sachs disease pathway , type 2 diabetes mellitus pathway Hk2 altered carbohydrate metabolic pathway , amino sugar metabolic pathway , butirosin and neomycin biosynthetic pathway , congenital sucrase-isomaltase deficiency pathway , Fanconi syndrome pathway , fructose and mannose metabolic pathway , fructose-1,6-bisphosphatase deficiency pathway , galactose metabolic pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type III pathway , glycogen storage disease type IV pathway , glycogen storage disease type VI pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , insulin signaling pathway , nucleotide sugar metabolic pathway , phosphoenolpyruvate carboxykinase deficiency pathway , starch and sucrose metabolic pathway , triosephosphate isomerase deficiency pathway , type 2 diabetes mellitus pathway Hk3 amino sugar metabolic pathway , butirosin and neomycin biosynthetic pathway , fructose and mannose metabolic pathway , galactose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , nucleotide sugar metabolic pathway , starch and sucrose metabolic pathway , type 2 diabetes mellitus pathway Ldha cysteine and methionine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , propanoate metabolic pathway , pyruvate metabolic pathway Ldhal1 cysteine and methionine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , propanoate metabolic pathway , pyruvate metabolic pathway Ldhal6b cysteine and methionine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , malonic aciduria pathway , methylmalonic aciduria, cobalamin-related pathway , propanoate metabolic pathway , pyruvate metabolic pathway Ldhb cysteine and methionine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , propanoate metabolic pathway , pyruvate metabolic pathway Ldhc cysteine and methionine metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , propanoate metabolic pathway , pyruvate metabolic pathway Pank1 Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , pantothenic acid metabolic pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Pck1 citric acid cycle pathway , eicosanoid signaling pathway via peroxisome proliferator-activated receptor gamma , forkhead class A signaling pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , Leigh disease pathway , phosphoenolpyruvate carboxykinase deficiency pathway , primary hyperoxaluria type 2 pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , triosephosphate isomerase deficiency pathway Pck2 citric acid cycle pathway , eicosanoid signaling pathway via peroxisome proliferator-activated receptor gamma , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , pyruvate metabolic pathway Pdha1 butanoate metabolic pathway , citric acid cycle pathway , fumaric aciduria pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , Leigh disease pathway , mitochondrial complex II deficiency pathway , primary hyperoxaluria type 2 pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate dehydrogenase E2 deficiency pathway , pyruvate dehydrogenase E3 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , valine, leucine and isoleucine biosynthetic pathway Pdha2 butanoate metabolic pathway , citric acid cycle pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , pyruvate metabolic pathway , valine, leucine and isoleucine biosynthetic pathway Pdhb butanoate metabolic pathway , citric acid cycle pathway , fumaric aciduria pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , Leigh disease pathway , mitochondrial complex II deficiency pathway , primary hyperoxaluria type 2 pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate dehydrogenase E2 deficiency pathway , pyruvate dehydrogenase E3 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , valine, leucine and isoleucine biosynthetic pathway Pfkfb1 fructose and mannose metabolic pathway , fructosuria pathway , gluconeogenesis pathway , glycolysis pathway , hereditary fructose intolerance syndrome pathway Pfkfb2 fructose and mannose metabolic pathway , glycolysis pathway Pfkfb3 fructose and mannose metabolic pathway , glycolysis pathway , hypoxia inducible factor pathway Pfkfb4 fructose and mannose metabolic pathway , glycolysis pathway Pfkl fructose and mannose metabolic pathway , fructosuria pathway , galactose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , hypoxia inducible factor pathway , pentose phosphate pathway , ribose 5-phosphate isomerase deficiency pathway , transaldolase deficiency pathway Pfkm Fanconi syndrome pathway , fructose and mannose metabolic pathway , galactose metabolic pathway , gluconeogenesis pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , pentose phosphate pathway Pfkp fructose and mannose metabolic pathway , galactose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , pentose phosphate pathway Pgam1 Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Pgam2 Fanconi syndrome pathway , fructose-1,6-bisphosphatase deficiency pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Pgk1 gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , lamivudine pharmacokinetics pathway Pgk1l1 gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Pgk2 gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway Pgm1 amino sugar metabolic pathway , congenital sucrase-isomaltase deficiency pathway , fructose-1,6-bisphosphatase deficiency pathway , galactokinase deficiency pathway , galactose metabolic pathway , galactosemia pathway , GALE deficiency pathway , gluconeogenesis pathway , glycogen biosynthetic pathway , glycogen degradation pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type III pathway , glycogen storage disease type IV pathway , glycogen storage disease type VI pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hypoxia inducible factor pathway , nucleotide sugar metabolic pathway , pentose phosphate pathway , phosphoenolpyruvate carboxykinase deficiency pathway , purine metabolic pathway , ribose 5-phosphate isomerase deficiency pathway , starch and sucrose metabolic pathway , transaldolase deficiency pathway , triosephosphate isomerase deficiency pathway Pklr Fanconi syndrome pathway , forkhead class A signaling pathway , gluconeogenesis pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , insulin signaling pathway , Leigh disease pathway , maturity-onset diabetes of the young pathway , primary hyperoxaluria type 2 pathway , purine metabolic pathway , pyruvate decarboxylase deficiency pathway , pyruvate dehydrogenase E1 deficiency pathway , pyruvate kinase deficiency of red cells pathway , pyruvate metabolic pathway , type 2 diabetes mellitus pathway Pkm glycolysis pathway , hypoxia inducible factor pathway , pyruvate metabolic pathway Slc2a2 facilitative sugar transporter mediated glucose transport pathway , Fanconi syndrome pathway , forkhead class A signaling pathway , fructose-1,6-bisphosphatase deficiency pathway , gliclazide pharmacodynamics pathway , gluconeogenesis pathway , glyburide pharmacodynamics pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , insulin secretion pathway , lactose degradation pathway , maturity-onset diabetes of the young pathway , phosphoenolpyruvate carboxykinase deficiency pathway , potassium channel inhibitors pharmacodynamics pathway , trehalose degradation pathway , triosephosphate isomerase deficiency pathway , type 2 diabetes mellitus pathway Tpi1 Fanconi syndrome pathway , fructose and mannose metabolic pathway , fructose-1,6-bisphosphatase deficiency pathway , fructosuria pathway , gluconeogenesis pathway , glycogen storage disease type Ia pathway , glycogen storage disease type Ib pathway , glycogen storage disease type VII pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , hereditary fructose intolerance syndrome pathway , inositol phosphate metabolic pathway , phosphoenolpyruvate carboxykinase deficiency pathway , triosephosphate isomerase deficiency pathway Tpi1l2 fructose and mannose metabolic pathway , gluconeogenesis pathway , glycolysis pathway , glycolysis/gluconeogenesis pathway , inositol phosphate metabolic pathway
2-aminoadipic 2-oxoadipic aciduria pathway Aldh7a1 , Dld 3-hydroxy-3-methylglutaryl-CoA lyase deficiency pathway Aldh2 , Dld 3-hydroxyisobutyric aciduria pathway Aldh2 , Dld 3-methylcrotonyl CoA carboxylase 1 deficiency pathway Aldh2 , Dld 3-methylglutaconic aciduria type 1 pathway Aldh2 , Dld 3-methylglutaconic aciduria type 3 pathway Aldh2 , Dld alkaptonuria pathway Aldh3a1 altered carbohydrate metabolic pathway Hk2 altered galactose metabolic pathway G6pc1 Alzheimer's disease pathway Gapdh , Gapdh-ps118 , Gapdhl10 , Gapdhl3 , Gapdhl9 amino sugar metabolic pathway Gck , Gpi , Hk1 , Hk2 , Hk3 , Pgm1 arginine and proline metabolic pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 ascorbate and aldarate metabolic pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 beta-alanine metabolic pathway Aldh1a1 , Aldh1a3 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldh7a1 , Aldh9a1 butanoate metabolic pathway Pdha1 , Pdha2 , Pdhb butirosin and neomycin biosynthetic pathway Gck , Hk1 , Hk2 , Hk3 carnitine biosynthetic pathway Aldh9a1 carnosinemia pathway Aldh2 choline metabolic pathway Aldh7a1 citric acid cycle pathway Dlat , Dld , Pck1 , Pck2 , Pdha1 , Pdha2 , Pdhb congenital sucrase-isomaltase deficiency pathway Gck , Gpi , Hk2 , Pgm1 cyclophosphamide pharmacodynamics pathway Aldh1a1 , Aldh3a1 cyclophosphamide pharmacokinetics pathway Aldh1a1 , Aldh3a1 cysteine and methionine metabolic pathway Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc D-glycericacidemia pathway Aldh3a1 dihydropyrimidine dehydrogenase deficiency pathway Aldh2 , Dld dimethylglycine dehydrogenase deficiency pathway Aldh2 , Dld disulfiram pharmacodynamics pathway Acss1 , Acss2 , Aldh1b1 , Aldh2 , Aldh3a1 dopamine beta-hydroxylase deficiency pathway Aldh3a1 doxorubicin pharmacokinetics pathway Akr1a1 eicosanoid signaling pathway via peroxisome proliferator-activated receptor gamma Pck1 , Pck2 electron transport chain pathway Gapdh facilitative sugar transporter mediated glucose transport pathway Slc2a2 familial lipoprotein lipase deficiency pathway Aldh3a1 Fanconi syndrome pathway Aldoa , Aldoart2 , Bpgm , Eno1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pfkm , Pgam1 , Pgam2 , Pklr , Slc2a2 , Tpi1 fatty acid beta degradation pathway Acss1 , Acss2 fatty acid metabolic pathway Adh4 , Adh5 , Adh6 , Adh7 , Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 felbamate pharmacokinetics pathway Aldh3a1 folate cycle metabolic pathway Dld forkhead class A signaling pathway Aldob , G6pc1 , Gck , Pck1 , Pklr , Slc2a2 french type sialuria pathway Hk1 fructose and mannose metabolic pathway Aldoa , Aldoart2 , Aldob , Aldoc , Fbp1 , Fbp2 , Hk1 , Hk2 , Hk3 , Pfkfb1 , Pfkfb2 , Pfkfb3 , Pfkfb4 , Pfkl , Pfkm , Pfkp , Tpi1 , Tpi1l2 fructose-1,6-bisphosphatase deficiency pathway Aldoa , Aldoart2 , Bpgm , Eno1 , Fbp1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pck1 , Pgam1 , Pgam2 , Pgm1 , Slc2a2 , Tpi1 fructosuria pathway Aldoa , Aldoart2 , Aldob , Fbp1 , Hk1 , Pfkfb1 , Pfkl , Tpi1 fumaric aciduria pathway Dlat , Dld , Pdha1 , Pdhb GABA aminotransferase deficiency pathway Aldh2 galactokinase deficiency pathway Gck , Pgm1 galactose metabolic pathway G6pc1 , Gck , Hk1 , Hk2 , Hk3 , Pfkl , Pfkm , Pfkp , Pgm1 galactosemia pathway G6pc1 , Gck , Hk1 , Pgm1 GALE deficiency pathway Gck , Pgm1 gliclazide pharmacodynamics pathway Slc2a2 gluconeogenesis pathway Acss1 , Acss2 , Adh4 , Adh5 , Adh6 , Adh7 , Adpgk , Akr1a1 , Aldh1a1 , Aldh1a3 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldh7a1 , Aldh9a1 , Aldoa , Aldoart2 , Aldob , Aldoc , Bpgm , Dlat , Dld , Eno1 , Eno2 , Eno3 , Fbp1 , Fbp2 , G6pc1 , Galm , Gapdh , Gapdh-ps118 , Gapdhl10 , Gapdhl3 , Gapdhl9 , Gapdhs , Gck , Gpi , Hk1 , Hk2 , Hk3 , Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc , Pank1 , Pck1 , Pck2 , Pdha1 , Pdha2 , Pdhb , Pfkfb1 , Pfkl , Pfkm , Pfkp , Pgam1 , Pgam2 , Pgk1 , Pgk1l1 , Pgk2 , Pgm1 , Pklr , Slc2a2 , Tpi1 , Tpi1l2 Glut1 deficiency syndrome pathway G6pc1 glutaric aciduria type I pathway Aldh7a1 , Dld glyburide pharmacodynamics pathway Slc2a2 glycerol kinase deficiency pathway Aldh3a1 glycerolipid metabolic pathway Akr1a1 , Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh7a1 , Aldh9a1 glycine, serine and threonine metabolic pathway Aldh7a1 , Dld glycogen biosynthetic pathway Gck , Pgm1 glycogen degradation pathway Pgm1 glycogen metabolic pathway Gck glycogen storage disease type Ia pathway Aldoa , Aldoart2 , Bpgm , Eno1 , Fbp1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pck1 , Pgam1 , Pgam2 , Pgm1 , Slc2a2 , Tpi1 glycogen storage disease type Ib pathway Aldoa , Aldoart2 , Bpgm , Eno1 , Fbp1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pck1 , Pgam1 , Pgam2 , Pgm1 , Slc2a2 , Tpi1 glycogen storage disease type III pathway Gck , Gpi , Hk2 , Pgm1 glycogen storage disease type IV pathway Gck , Gpi , Hk2 , Pgm1 glycogen storage disease type VI pathway Gck , Gpi , Hk2 , Pgm1 glycogen storage disease type VII pathway Aldoa , Aldoart2 , Bpgm , Eno1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pfkm , Pgam1 , Pgam2 , Pklr , Slc2a2 , Tpi1 glycolysis pathway Acss1 , Acss2 , Adh4 , Adh5 , Adh6 , Adh7 , Adpgk , Akr1a1 , Aldh1a1 , Aldh1a3 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldh7a1 , Aldh9a1 , Aldoa , Aldoart2 , Aldob , Aldoc , Bpgm , Dlat , Dld , Eno1 , Eno2 , Eno3 , Fbp1 , Fbp2 , G6pc1 , Galm , Gapdh , Gapdh-ps118 , Gapdhl10 , Gapdhl3 , Gapdhl9 , Gapdhs , Gck , Gpi , Hk1 , Hk2 , Hk3 , Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc , Pank1 , Pck1 , Pck2 , Pdha1 , Pdha2 , Pdhb , Pfkfb1 , Pfkfb2 , Pfkfb3 , Pfkfb4 , Pfkl , Pfkm , Pfkp , Pgam1 , Pgam2 , Pgk1 , Pgk1l1 , Pgk2 , Pgm1 , Pklr , Pkm , Slc2a2 , Tpi1 , Tpi1l2 glycolysis/gluconeogenesis pathway Acss1 , Acss2 , Adh4 , Adh5 , Adh6 , Adh7 , Adpgk , Akr1a1 , Aldh1a1 , Aldh1a3 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldh7a1 , Aldh9a1 , Aldoa , Aldob , Aldoc , Bpgm , Dlat , Dld , Eno1 , Eno2 , Eno3 , Fbp1 , Fbp2 , G6pc1 , Galm , Gapdh , Gapdh-ps118 , Gapdhl10 , Gapdhl3 , Gapdhl9 , Gapdhs , Gck , Gpi , Hk1 , Hk2 , Hk3 , Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc , Pck1 , Pck2 , Pdha1 , Pdha2 , Pdhb , Pfkl , Pfkm , Pfkp , Pgam1 , Pgam2 , Pgk1 , Pgk1l1 , Pgk2 , Pgm1 , Pklr , Tpi1 , Tpi1l2 hawkinsinuria pathway Aldh3a1 hereditary fructose intolerance syndrome pathway Aldoa , Aldoart2 , Aldob , Fbp1 , Hk1 , Pfkfb1 , Pfkl , Tpi1 hexosamine biosynthetic pathway Gpi histidine metabolic pathway Aldh1a1 , Aldh1a3 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a1 , Aldh3a2 , Aldh3b1 , Aldh7a1 , Aldh9a1 histidinemia pathway Aldh2 , Aldh3a1 hyperlysinemia pathway Aldh7a1 , Dld hypoxia inducible factor pathway Aldoa , Aldoart2 , Eno1 , Gck , Hk1 , Hk2 , Ldha , Pfkfb3 , Pfkl , Pgk1 , Pgm1 , Pkm ifosfamide pharmacodynamics pathway Aldh1a1 , Aldh3a1 ifosfamide pharmacokinetics pathway Aldh1a1 , Aldh3a1 inositol phosphate metabolic pathway Tpi1 , Tpi1l2 insulin secretion pathway Gck , Slc2a2 insulin signaling pathway Fbp1 , Fbp2 , G6pc1 , Gck , Hk1 , Hk2 , Hk3 , Pck1 , Pck2 , Pklr isobutyryl-CoA dehydrogenase deficiency pathway Aldh2 , Dld isovaleric acidemia pathway Aldh2 , Dld lactose biosynthetic pathway G6pc1 lactose degradation pathway Slc2a2 lamivudine pharmacokinetics pathway Pgk1 Leigh disease pathway Acss2 , Aldh2 , Dlat , Dld , Pck1 , Pdha1 , Pdhb , Pklr lysine biosynthetic pathway Aldh7a1 lysine degradation pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 , Dld malonic aciduria pathway Acss1 , Dld , Ldhal6b maple syrup urine disease pathway Aldh2 , Dld maturity-onset diabetes of the young pathway Gck , Pklr , Slc2a2 methylmalonate semialdehyde dehydrogenase deficiency pathway Aldh2 , Dld methylmalonic acidemia pathway Aldh2 , Dld methylmalonic aciduria, cobalamin-related pathway Acss1 , Dld , Ldhal6b mitochondrial complex II deficiency pathway Dlat , Dld , Pdha1 , Pdhb neviparine pharmacokinetics pathway Aldh1a1 nicotinamide adenine dinucleotide metabolic pathway Gapdh nonketotic hyperglycinemia pathway Aldh2 , Dld Notch signaling pathway Eno1 nucleotide sugar metabolic pathway Gck , Gpi , Hk1 , Hk2 , Hk3 , Pgm1 pantothenic acid metabolic pathway Pank1 pentose and glucuronate interconversion pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 pentose phosphate pathway Aldoa , Aldoart2 , Aldob , Aldoc , Fbp1 , Fbp2 , Gpi , Pfkl , Pfkm , Pfkp , Pgm1 phase I biotransformation pathway via cytochrome P450 Adh4 , Adh5 , Adh6 , Adh7 , Aldh1a3 , Aldh3a1 , Aldh3b1 phenylalanine metabolic pathway Aldh1a3 , Aldh3a1 , Aldh3b1 phosphoenolpyruvate carboxykinase deficiency pathway Aldoa , Aldoart2 , Bpgm , Eno1 , Fbp1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pck1 , Pgam1 , Pgam2 , Pgm1 , Slc2a2 , Tpi1 phytanic acid degradation pathway Aldh3a2 potassium channel inhibitors pharmacodynamics pathway Slc2a2 primary hyperoxaluria type 2 pathway Acss2 , Aldh2 , Dlat , Dld , Pck1 , Pdha1 , Pdhb , Pklr propanoate metabolic pathway Acss1 , Acss2 , Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 , Dld , Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc propionic acidemia pathway Aldh2 , Dld prostaglandin biosynthetic pathway Akr1a1 purine metabolic pathway Pgm1 , Pklr pyruvate decarboxylase deficiency pathway Acss2 , Aldh2 , Dlat , Dld , Pck1 , Pdha1 , Pdhb , Pklr pyruvate dehydrogenase E1 deficiency pathway Acss2 , Aldh2 , Dlat , Dld , Pck1 , Pdha1 , Pdhb , Pklr pyruvate dehydrogenase E2 deficiency pathway Dlat , Dld , Pdha1 , Pdhb pyruvate dehydrogenase E3 deficiency pathway Dlat , Dld , Pdha1 , Pdhb pyruvate kinase deficiency of red cells pathway Acss2 , Aldh2 , Dlat , Dld , Pck1 , Pdha1 , Pdhb , Pklr pyruvate metabolic pathway Acss1 , Acss2 , Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 , Dlat , Dld , Ldha , Ldhal1 , Ldhal6b , Ldhb , Ldhc , Pck1 , Pck2 , Pdha1 , Pdha2 , Pdhb , Pklr , Pkm Refsum disease pathway Aldh3a2 remethylation pathway of homocysteine metabolism - cobalamin independent, betaine dependent Aldh7a1 retinoic acid metabolic pathway Aldh1a1 , Aldh1a3 retinol metabolic pathway Adh4 , Adh5 , Adh6 , Adh7 , Aldh1a1 ribose 5-phosphate isomerase deficiency pathway Aldoa , Aldoart2 , Fbp1 , Gpi , Pfkl , Pgm1 RNA degradation pathway Eno1 , Eno2 , Eno3 saccharopinuria pathway Aldh7a1 , Dld sarcosinemia pathway Aldh2 , Dld sialic acid storage disease pathway Hk1 starch and sucrose metabolic pathway G6pc1 , Gck , Gpi , Hk1 , Hk2 , Hk3 , Pgm1 Tay-Sachs disease pathway Hk1 transaldolase deficiency pathway Aldoa , Aldoart2 , Fbp1 , Gpi , Pfkl , Pgm1 trehalose degradation pathway Gck , Slc2a2 triosephosphate isomerase deficiency pathway Aldoa , Aldoart2 , Bpgm , Eno1 , Fbp1 , G6pc1 , Galm , Gapdh , Gpi , Hk2 , Pank1 , Pck1 , Pgam1 , Pgam2 , Pgm1 , Slc2a2 , Tpi1 tryptophan metabolic pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 type 2 diabetes mellitus pathway Gck , Hk1 , Hk2 , Hk3 , Pklr , Slc2a2 tyrosine metabolic pathway Adh4 , Adh5 , Adh6 , Adh7 , Aldh1a3 , Aldh3a1 , Aldh3b1 tyrosinemia type I pathway Aldh3a1 valine, leucine and isoleucine biosynthetic pathway Pdha1 , Pdha2 , Pdhb valine, leucine and isoleucine degradation pathway Aldh1a1 , Aldh1a7 , Aldh1b1 , Aldh2 , Aldh3a2 , Aldh7a1 , Aldh9a1 , Dld vitamin A deficiency pathway Aldh1a1
References Associated with the glycolysis pathway:
Bouche C, etal., Endocr Rev. 2004 Oct;25(5):807-30.
Vora S, etal., Biochem J. 1985 Jul 15;229(2):333-41.
Cardenas ML, etal., Biochim Biophys Acta. 1998 Mar 5;1401(3):242-64.
Rider MH, etal., Biochem J. 2004 Aug 1;381(Pt 3):561-79.
Rigden DJ Biochem J. 2008 Jan 15;409(2):333-48.
Rutter WJ, etal., Ann N Y Acad Sci. 1968 Jun 14;151(1):102-17.
Ratnakumari L and Murthy CR, Neurosci Lett. 1993 Oct 14;161(1):37-40.
Masters CJ, etal., Mol Cell Biochem. 1987 Jul;76(1):3-14.
Hers HG and Hue L, Annu Rev Biochem. 1983;52:617-53.
Van Schaftingen E, Diabetologia. 1993 Jul;36(7):581-8.
Ontology Path Diagram:
Import into Pathway Studio: